Could sleep boost waste disposal in the brain and prevent Parkinson’s?
Date
Research news
People with ADHD may be at increased risk of Parkinson's
Date
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
Positive results for a breath test for Parkinson's
Date
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
New cell transplant trial to start in Japan
Date
Researchers in Japan have announced clinical trials of a stem cell-based treatment for Parkinson's will start this month.
Brain scan provides vital tool to improve clinical trials
Date
Researchers and drug companies have a new tool in the search for better treatments for Parkinson's - a brain scan that can be used to select the right people for clinical trials.
Research shows targeting LRRK2 could benefit many with Parkinson's
Date
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
Diabetes-type drug may slow Parkinson's
Date
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Study finds potential benefits of vitamin B3
Date
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Exenatide found to have positive effect on mood
Date
Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
UK-wide trial to test treatment for balance, walking and falls
Date
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
Promising results from first year of NTCELL trial
Date
The latest update, one year into a clinical trial happening in Australia and New Zealand, show promising results for the safety and effectiveness of NTCELL® therapy.